Evaluation of an oral uracil loading test to identify DPD-deficient patients using a limited sampling strategy.
about
New advances in DPYD genotype and risk of severe toxicity under capecitabine.Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.Therapeutic drug monitoring of 5-fluorouracil.Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients.
P2860
Evaluation of an oral uracil loading test to identify DPD-deficient patients using a limited sampling strategy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluation of an oral uracil l ...... g a limited sampling strategy.
@ast
Evaluation of an oral uracil l ...... g a limited sampling strategy.
@en
type
label
Evaluation of an oral uracil l ...... g a limited sampling strategy.
@ast
Evaluation of an oral uracil l ...... g a limited sampling strategy.
@en
prefLabel
Evaluation of an oral uracil l ...... g a limited sampling strategy.
@ast
Evaluation of an oral uracil l ...... g a limited sampling strategy.
@en
P2093
P2860
P356
P1476
Evaluation of an oral uracil l ...... g a limited sampling strategy.
@en
P2093
Andre B P van Kuilenburg
Cornelis J A Punt
Hans Gelderblom
Jan Gerard Maring
Judith Meijer
Maurice C van Staveren
Robert S de Jong
P2860
P304
P356
10.1111/BCP.12821
P407
P577
2015-11-09T00:00:00Z